Ana Rodríguez, Author at Baylor College of Medicine Blog Network

How neutrophils help triple-negative breast cancer cells spread to other organs

June 30, 2026 epithelial-like, ICAM1-high, macrophages, mesenchymal-like, Metastasis, neutrophils, Research, triple-negative breast cancer

The researchers found that the interaction between neutrophils and epithelial-like cancer cells helps both types of cells survive.

From The Labs

BCM and TCH researcher awarded up to $17.25 million to become part of The Aligning Research to Impact Autism (ARIA) IMPACT Network to accelerate clinical research for autism

June 25, 2026 ARIA, Autism, Award, IMPACT Network, Research

Joining the ARIA IMPACT Network will allow Baylor and Texas Children’s to accelerate our breakthrough work to bring effective therapies to people with autism and related neurodevelopmental disorders.

From The Labs

Dr. Kara Marshall has been awarded the 2026 McKnight Endowment Fund

June 23, 2026 Anxiety, Awards, fear, McKnight Scholar Award, mechanosensation, Research

This award will support Marshall’s work investigating the role the body’s nervous system plays in emotion states and behavior.

From The Labs

Wastewater analysis offers a new way to monitor HIV in communities

June 18, 2026 HIV, hybrid-capture genetic sequencing, lentiviral vector, Research, Texas, wastewater surveillance

The team uncovered a significant association between HIV signals in wastewater and diagnosed HIV in communities.

From The Labs

Diet remodels chromatin structure and extends survival in models of glioma

June 16, 2026 brain tumor, chromatin organizer, Glioma, Hp1bp3, methionine, Research

The findings reveal a connection between diet, gene regulation and cancer growth that opens new possibilities for treating one of the most aggressive brain tumors.

From The Labs

Researchers studied female Rett syndrome in detail for the first time

June 11, 2026 early genetic changes in Rett syndrome, MECP2, Research, Rett Syndrome

Understanding early and cell-specific changes in Rett syndrome provides markers to monitor efficacy of interventions and entry points to understand the brain circuits driving the condition.